Company News, Financial News

Lonza To Sell Specialty Chemicals Business

The move puts the company's focus on pharmaceutical ingredients.

Author Image

By: TOM BRANNA

Editor

Lonza is exiting the specialty chemicals business to focus on pharmaceuticals. Bain Capital and Cinven have agreed to purchase Lonza’s specialty ingredients business and operations for an enterprise value of CHF 4.2 billion (about $4.66 billion). “Today’s announcement is the result of a comprehensive and robust selection process. Bain Capital and Cinven have shown they understand the value of the experience and expertise of our specialty ingredients employees,” said Lonza Chairman Albe...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters